CIK 0000860730
HCA HCA Healthcare, Inc.
Insider trading from SEC Form 4. Last filing Nov 14, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at HCA Healthcare, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 48Moderate | sell 2 | Akdamar Erol R Group President | $1.0M | 2,900 | -30% | - | |
| 33Weak | sell 2 | Billington Phillip G SVP-Internal Audit Services | $1.4M | 3,897 | -7% | - |
Congressional trades
4 trades in HCA disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Jared Moskowitz House · D-FL | Purchase | HCA HCA Healthcare, Inc. Common Stock | $1,001 to $15k | May 15, 2025 | 43 days after the trade |
| Jared Moskowitz House · D-FL | Purchase | HCA HCA Healthcare, Inc. Common Stock | $1,001 to $15k | May 15, 2025 | 43 days after the trade |
| Julie Johnson House · D-TX | Sale | HCA HCA Healthcare, Inc. Common Stock | $1,001 to $15k | Apr 7, 2025 | 37 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | HCA HCA Healthcare, Inc. Common Stock | $1,001 to $15k | Feb 25, 2025 | 30 days after the trade |
Transactions
The last 8 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | Akdamar Erol R Group President | MOption exercise Common Stock | +20,000 | $68.96 | $1.4M | 20,000 | Nov 14, 2024 |
| Nov 12, 2024 | Billington Phillip G SVP-Internal Audit Services | MOption exercise Common Stock | +8,000 | $68.96 | $552k | 60,702 | Nov 14, 2024 |
| Nov 12, 2024 | Akdamar Erol R Group President | FTax withholding Common Stock | -10,257 | $350.53 | $3.6M | 9,743 | Nov 14, 2024 |
| Nov 12, 2024 | Billington Phillip G SVP-Internal Audit Services | FTax withholding Common Stock | -4,103 | $350.53 | $1.4M | 56,599 | Nov 14, 2024 |
| Nov 14, 2024 | Akdamar Erol R Group President | SOpen-market sale Common Stock | -2,900 | $353.00 | $1.0M | 6,843 | Nov 14, 2024 |
| Nov 14, 2024 | Billington Phillip G SVP-Internal Audit Services | SOpen-market sale Common Stock | -3,897 | $350.00 | $1.4M | 52,702 | Nov 14, 2024 |
| Nov 12, 2024 | Billington Phillip G SVP-Internal Audit Services | MOption exercise Stock Appreciation Rightderivative | -8,000 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 12, 2024 | Akdamar Erol R Group President | MOption exercise Stock Appreciation Rightderivative | -20,000 | $0.00 | $0 | 0 | Nov 14, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Akdamar Erol RGroup President
- Billington Phillip GSVP-Internal Audit Services
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.